Altered vascular responses to circulating angiotensin II in familial combined hyperlipidemia

Journal of Cardiovascular Medicine

Volumn 9, Issue 10, 2008, Pages 1037-1044

  Jörneskog, Gun ^a,b   Kahan, Thomas ^b   Ekholm, Mikael ^b   Bröijersén, Anders ^c   Wallén, N Håkan ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Angiotensin; Blood pressure; Hyperlipidemia; Laser Doppler fluxmetry; Microcirculation

Indexed keywords

ANGIOTENSIN II; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTERIAL PRESSURE; ARTICLE; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; BRADYCARDIA; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FAMILIAL HYPERLIPEMIA; FEMALE; FOREARM; HEATING; HUMAN; HYPEREMIA; INSULIN RESISTANCE; LASER DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; PULSE PRESSURE; REST; SKIN BLOOD FLOW; SKIN TEMPERATURE; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR RESISTANCE; BLOOD FLOW; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CASE CONTROL STUDY; HEART RATE; HEAT; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; SKIN; TIME; VASCULARIZATION; VASODILATATION;

ADULT; ANGIOTENSIN II; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CASE-CONTROL STUDIES; FEMALE; HEART RATE; HEAT; HEMODYNAMICS; HUMANS; HYPEREMIA; HYPERLIPIDEMIA, FAMILIAL COMBINED; INFUSIONS, INTRAVENOUS; LASER-DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; MIDDLE AGED; REGIONAL BLOOD FLOW; SKIN; SKIN TEMPERATURE; TIME FACTORS; VASCULAR RESISTANCE; VASODILATION;

EID: 55249096747     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32830a48bd     Document Type: Article

References (36)

1. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 1992; 152:56-64.
2. Nickenig G, Jung O, Strehlow K, Zolk O, Linz W, Schölkens BA, et al. Hypercholesterolemia is associated with enhanced angiotensin AT1-receptor expression. Am J Physiol 1997; 272:H2701-H2707.
3. Pollock DM. Endothelin, angiotensin, and oxidative stress in hypertension. Hypertension 2005; 45:477-480.
4. Wassman S, Nickenig G. Pathophysiological regulation of the AT1-receptor and implications for vascular disease. J Hypertens Suppl 2006; 24:S15-S21.
5. van der Linde NA, Sijbrands EJ, Boomsma F, van den Meiracker AH. Effect of low-density lipoprotein cholesterol on angiotensin II sensitivity: a randomized trial with fluvastatin. Hypertension 2006; 47:1125-1130.
6. Feihl F, Liaudet L, Waeber B, Levy BI. Hypertension: a disease of the microcirculation? Hypertension 2006; 48:1012-1017.
7. Serné EH, Stehouwer CD, ter Maaten JC, ter Wee PM, Rauwerda JA, Donker AJ, et al. Microvascular function relates to insulin sensitivity and blood pressure in normal subjects. Circulation 1999; 99:896-902.
8. Noon JP, Walker BR, Webb DJ, Shore AC, Holton DW, Edwards HV, et al. Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest 1997; 99:1873- 1879.
9. Tripathi A, Nadel ER. Forearm skin and muscle vasoconstriction during lower body negative pressure. J Appl Physiol 1986; 60:1535-1541.
10. Steckelings UM, Wollschlager T, Peters J, Henz BM, Hermes B, Artuc M. Human skin: source of and target organ for angiotensin II. Exp Dermatol 2004; 13:148-154.
11. Gössl M, Mitchell A, Lerman A, Opazo Saez A, Schäfers RF, Erbel R, et al. Endothelin-B-receptor-selective antagonist inhibits endothelin-1 induced potentiation on the vasoconstriction to noradrenaline and angiotensin II. J Hypertension 2004; 22: 1909-1916.
12. Mitchell A, Rushentsova U, Siffert W, Philipp T, Wenzel R. The angiotensin II receptor antagonist valsartan inhibits endothelin 1-induced vasoconstriction in the skin microcirculation in humans in vivo: influence of the G-protein b3 subunit (GNB3) C825T polymorphism. Clin Pharmacol Ther 2006; 79:274-281.
13. Bredie SJ, Tack CJ, Smits P, Stalenhoef AF. Nonobese patients with familial combined hyperlipidemia are insulin resistant compared with their nonaffected relatives. Arterioscler Thromb Vasc Biol 1997; 17:1465- 1471.
14. Hopkins PN, Heiss G, Ellison RC, Province MA, Pankow JS, Eckfeldt JH, et al. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia. A case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study. Circulation 2003; 108:519-523.
15. Veerkamp MJ, de Graaf J, Stalenhoef AF. Role of insulin resistance in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 2005; 25: 1026-1031.
16. Gooding KM, Hannemann MM, Tooke JE, Clough GF, Shore AC. Maximum skin hyperaemia induced by local heating: possible mechanisms. J Vasc Res 2006; 43:270-277.
17. Kellogg DL Jr. In vivo mechanisms of cutaneous vasodilation and vasoconstriction in humans during thermoregulatory challenges. J Appl Physiol 2006; 100:1709-1718.
18. Leahy MJ, de Mul FF, Nilsson GE, Maniewski R. Principles and practice of the laser-Doppler perfusion technique. Technol Healthcare 1999; 7: 143- 162.
19. Nilsson GE, Tenland T, Öberg PA. Evaluation of a laser Doppler flowmeter for measurement of tissue blood flow. IEEE Trans Biomed Eng 1980; 27:597-604.
20. Caspary L, Creutzig A, Alexander K. Biological zero in laser Doppler fluxmetry. Int J Microcirc: Clin Exp 1988; 7: 367-371.
21. Carlson K. Lipoprotein fractionation. J Clin Pathol 1973; 26:32-37.
22. Lopes-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high density lipoproteins separated by three different methods. Clin Chem 1977; 23: 882-884.
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
24. Yki-Jarvinen H, Westerbacka J. Insulin resistance, arterial stiffness and wave reflection. Adv Cardiol 2007; 44:252-260.
25. ter Avest E, Holewijn A, Bredie SBJ, van Tits LJH, Stalenhoef AFH, de Graaf J. Pulse wave velocity in familial combined hyperlipidemia. Am J Hypertens 2007; 20:263-269.
26. Fang J, Madhavan S, Alderman MH. Pulse pressure. a predictor of cardiovascular mortality among young normotensive subjects. Blood Press 2000; 9:260-266.
27. Knudsen ST, Poulsen PL, Hansen KW, Ebbehoj E, Bek T, Mogensen CE. Pulse pressure and diurnal blood pressure variation: association with micro- and macrovascular complications in type 2 diabetes. Am J Hypertens 2002; 15:244-250.
28. Gohlke P, Pees C, Unger T. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension 1998; 31: 349-355.
29. Patzak A, Lai EY, Mrowka R, Steege A, Persson PB, Persson AE. AT1 receptors mediate angiotensin II-induced release of nitric oxide in afferent arterioles. Kidney Int 2004; 66:1949-1958.
30. Zhang Z, Rhinehart K, Solis G, Pittner J, Lee-Kwon W, Welch WJ, et al. Chronic ANG II infusion increases NO generation by rat descending vasa recta. Am J Physiol Heart Circ Physiol 2005; 288:H29-H36.
31. Iannuzzi A, Bianciardi G, Faccenda F, Gnasso A, Scarpato N, Di Marino L, et al. Correction of erythrocyte shape abnormalities in familial hypercholesterolemia after LDL-apheresis: does it influence cerebral hemodynamics? Heart Vessels 1997; 12:234-240.
32. Bishop VS, Sanderford MG. Angiotensin II modulation of the arterial baroreflex: role of the area postrema. Clin Exp Pharmacol Physiol 2000; 27:428-431.
33. Julius S, Majahalme S. The changing face of sympathetic overactivity in hypertension. Ann Med 2000; 32: 365-370.
34. Schwieler JH, Kahan T, Nussberger J, Hjemdahl P. Influence of the renin-angiotensin system on sympathetic neurotransmission in canine skeletal muscle in vivo. Naunyn Schmiedebergs Arch Pharmacol 1991; 343:166- 172.
35. Halperin RO, Sesso HD, Ma J, Buring JE, Stampfer MJ, Gaziano JM. Dyslipidemia and the risk of incident hypertension in men. Hypertension 2006; 47:45-50.
36. Folkow B. Physiological aspects of primary hypertension. Physiol Rev 1982; 62:347-504.